Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
To observe the efficacy and safety of adebelizumab combined with chemotherapy and sequential
adebelizumab combined with radiotherapy in the treatment of newly diagnosed extensive small
cell lung cancer.